Large-scale testing (Phase 3)Study completedNCT01466062
What this trial is testing
Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions
Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 28